Eton Pharmaceuticals, Inc.ETONNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
7.59%
↑ 114% above average
Average (33q)
-52.50%
Historical baseline
Range
High:253.24%
Low:-487.14%
Volatility
-1410.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 7.59% |
| Q2 2025 | -213.83% |
| Q1 2025 | -174.72% |
| Q4 2024 | 23.58% |
| Q3 2024 | 117.34% |
| Q2 2024 | -266.88% |
| Q1 2024 | 59.86% |
| Q4 2023 | -263.69% |
| Q3 2023 | -114.11% |
| Q2 2023 | 253.24% |
| Q1 2023 | -338.61% |
| Q4 2022 | 136.68% |
| Q3 2022 | -116.04% |
| Q2 2022 | 73.66% |
| Q1 2022 | -487.14% |
| Q4 2021 | 122.47% |
| Q3 2021 | -151.48% |
| Q2 2021 | -143.35% |
| Q1 2021 | 172.28% |
| Q4 2020 | -18.30% |
| Q3 2020 | -38.21% |
| Q2 2020 | 48.90% |
| Q1 2020 | -234.38% |
| Q4 2019 | 47.32% |
| Q3 2019 | -50.55% |
| Q2 2019 | 55.67% |
| Q1 2019 | -230.45% |
| Q4 2018 | 3.71% |
| Q3 2018 | 11.98% |
| Q2 2018 | 9.01% |
| Q1 2018 | 48.64% |
| Q4 2017 | -108.34% |
| Q3 2017 | -26.83% |
| Q2 2017 | 0.00% |